Riskpilot← Back to searchSign inGet full accessPHARMA ACTIVE AS
ASActiveOrg 993341843Hattemakerlia 153, 2019 SkedsmokorsetRental and operating of own or leased real estate · NACE 6820Est. 20080 employees
Revenue 2024
NOK 484K
-41% vs 2023
EBITDA margin
-84.8%
-4176% vs 2023
Equity ratio
34.3%
Financial strength
Net profit 2024
NOK 1,3M
-79% vs 2023
| Revenue | NOK 484K | -41% |
| EBITDA | NOK -411K | -4176% |
| Net profit | NOK 1,3M | -79% |
| Total assets | NOK 39,3M | -12% |
| Equity | NOK 13,5M | -21% |
| Employees | 0 | — |
Legal name
PHARMA ACTIVE AS
Org number
993341843
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
22. november 2008
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Huu erica thien khuong
Company purpose
Eie aksjer og andeler i andre selskaper og sammenslutninger, investering i og drift av fast eiendom, samt andre aktiviteter i naturlig sammenheng med dette.
Address
Hattemakerlia 153, 2019 Skedsmokorset
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 288 | 455 | 1 009 | 814 | 484 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 101 | 317 | 598 | −10 | −411 |
| Depreciation & amort. | −0 | −0 | −44 | −87 | −1 073 |
| EBIT | 101 | 317 | 555 | −97 | −1 484 |
| Net financials | 5 513 | 6 730 | −1 426 | 6 091 | 2 391 |
| Profit before tax | 5 615 | 7 048 | −871 | 5 994 | 907 |
| Tax | −0 | −0 | 140 | −151 | −401 |
| Net profit | 5 615 | 7 048 | −1 011 | 6 145 | 1 308 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 54 714 | 60 302 | 48 710 | 44 396 | 39 267 |
| Equity | 37 980 | 42 241 | 23 222 | 17 039 | 13 477 |
| Long-term debt | 2 323 | 15 100 | 13 928 | 12 699 | 12 451 |
| Short-term debt | 14 411 | 2 961 | 11 559 | 14 658 | 13 338 |
| Total debt | 16 734 | 18 061 | 25 487 | 27 357 | 25 789 |
EBITDA margin
-84.8%
This company
15.8%
Market median
-637% vs market
20202024
Equity ratio
34.3%
This company
38.2%
Market median
+10% vs market
20202024
Return on equity
9.7%
This company
18.4%
Market median
-47% vs market
20202024
Net profit margin
270.2%
This company
8.1%
Market median
+3236% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
1.91×
This company
0.62×
Market median
-208% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2018 | |
| Chairman | 2018 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
PHARMA ACTIVE AS (this company)
APOTEKFORDEG ASBoard members of PHARMA ACTIVE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Huu Erica Thien Khuong | Board of Directors | 0 companies |
| Martin Le | Chairman | 0 companies |